The cytotoxicity of DNA carboxymethylation and methylation by the model carboxymethylating agent azaserine in human cells

被引:30
作者
O'Driscoll, M
Macpherson, P
Xu, YZ
Karran, P [1 ]
机构
[1] Imperial Canc Res Fund, Clare Hall Labs, S Mimms EN6 3LD, Herts, England
[2] UCL, Dept Biochem & Mol Biol, CRC Nitrosamine Induced Canc Res Grp, London WC1E 6BT, England
关键词
D O I
10.1093/carcin/20.9.1855
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Carboxymethylating agents are potential sources of endogenous DNA damage that have been proposed as possible contributors to gastrointestinal carcinogenesis. The cytotoxicity of the model DNA carboxymethylating agent azaserine was investigated in human cells, Expression of the DNA repair enzyme O-6-methylguanine-DNA methyltransferase (MGMT) did not affect sensitivity to the drug in two related Raji Burkitt's lymphoma cell lines. DNA mismatch repair-defective variants of Raji cells which display increased tolerance to DNA methylation damage were not selectively resistant to azaserine, Complementary results were obtained with a second carboxymethylating agent, potassium diazoacetate. In contrast, lymphoblastoid cell lines representative of each of the xeroderma pigmentosum complementation groups, including the variant, were all significantly more sensitive to azaserine than nucleotide excision repair-proficient cells. The hypersensitivity of XP cells was not due to systematic differences in the concentrations of intracellular thiol compounds or related thiol metabolizing enzymes. The data indicate that of the two types of potentially lethal DNA damage which azaserine introduces, carboxymethylated bases and O-6-methylguanine, the former are repaired by nucleotide excision repair and are a more significant contributor to azaserine lethality in human cells.
引用
收藏
页码:1855 / 1862
页数:8
相关论文
共 48 条
[1]  
Aquilina G, 1998, CANCER RES, V58, P135
[2]   DEFECTIVE MISMATCH BINDING AND A MUTATOR PHENOTYPE IN CELLS TOLERANT TO DNA DAMAGE [J].
BRANCH, P ;
AQUILINA, G ;
BIGNAMI, M ;
KARRAN, P .
NATURE, 1993, 362 (6421) :652-654
[3]  
BRANCH P, 1995, CANCER RES, V55, P2304
[4]   Processing of O-6-methylguanine by mismatch correction in human cell extracts [J].
Ceccotti, S ;
Aquilina, G ;
Macpherson, P ;
Yamada, M ;
Karran, P ;
Bignami, M .
CURRENT BIOLOGY, 1996, 6 (11) :1528-1531
[5]   Increased somatic recombination in methylation tolerant human cells with defective DNA mismatch repair [J].
Ciotta, C ;
Ceccotti, S ;
Aquilina, G ;
Humbert, O ;
Palombo, F ;
Jiricny, J ;
Bignami, M .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 276 (04) :705-719
[6]   ISOLATION OF AN HMSH2-P160 HETERODIMER THAT RESTORES DNA MISMATCH REPAIR TO TUMOR-CELLS [J].
DRUMMOND, JT ;
LI, GM ;
LONGLEY, MJ ;
MODRICH, P .
SCIENCE, 1995, 268 (5219) :1909-1912
[7]   Human MutS alpha recognizes damaged DNA base pairs containing O-6-methylguanine, O-4-methylthymine, or the cisplatin-d(GpG) adduct [J].
Duckett, DR ;
Drummond, JT ;
Murchie, AIH ;
Reardon, JT ;
Sancar, A ;
Lilley, DM ;
Modrich, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (13) :6443-6447
[8]  
FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES
[9]   Isolation of MutSβ from human cells and comparison of the mismatch repair specificities of MutSβ and MutSα [J].
Genschel, J ;
Littman, SJ ;
Drummond, JT ;
Modrich, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (31) :19895-19901
[10]  
GOLDIN BR, 1986, ANNU REV MICROBIOL, V40, P367, DOI 10.1146/annurev.micro.40.1.367